Lamar Advertising (NASDAQ:LAMR – Get Free Report) has been assigned a consensus recommendation of “Hold” from the five ratings firms that are covering the firm, Ratings reports. Four investment ...

Analysts at HC Wainwright began coverage on shares of Nuvalent (NASDAQ:NUVL – Get Free Report) in a research report issued on ...

Upon completion of the proposed merger, Oqory, Inc. will merge with Vincerx Pharma, Inc. Post-closing, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx ...

After a stellar 2023, it was a great year for growth stocks in the software space like Palantir Technologies and AppLovin after the S&P 500 and Nasdaq composite confirmed new uptrends in early ...

Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting ...

2-Year U.S. Treasury Note Continuous Contract $102.836 0.023 0.02% 5-Year U.S. Treasury Note Continuous Contract $106.477 0.078 0.07% 10-Year U.S. Treasury Note Continuous Contract $109.125 0.156 ...

In retrospect, it was inevitable.Down more than 8% and holding just above $300 on Monday, MicroStrategy (MSTR) shares are now lower by about 30% ...

2-Year U.S. Treasury Note Continuous Contract $102.668-0.012-0.01% 5-Year U.S. Treasury Note Continuous Contract $106.016-0.023-0.02% 10-Year U.S. Treasury Note Continuous Contract $108.375-0.063 ...

Shares of this specialty technology company have gained 141% over the past year, and that could be just the beginning.

In this podcast, Motley Fool analyst Asit Sharma and host Ricky Mulvey discuss: Microstrategy 's entrance into the Nasdaq-100 ...